+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Diabetes Injection Pens Market Research Report by Product, by Usage, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4989869
  • Report
  • July 2021
  • Region: Global
  • 197 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Diabetes Injection Pens Market will Grow to USD 19.55 Billion by 2026, at a CAGR of 5.68%

FEATURED COMPANIES

  • AstraZeneca plc
  • Biocon Ltd.
  • Eli Lilly and Company
  • Insulet Corporation
  • Jiangsu Delfu Co.
  • Medtronic Plc
  • MORE
The Global Diabetes Injection Pens Market size was estimated at USD 14.03 Billion in 2020 and expected to reach USD 14.78 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 5.68% to reach USD 19.55 Billion by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Diabetes Injection Pens to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the Diabetes Injection Pens Market was studied across Insulin Pens and Pen Needles.
  • Based on Distribution Channel, the Diabetes Injection Pens Market was studied across Diabetes Clinics, Hospital Pharmacy, Online Sales, and Retail Pharmacy.
  • Based on Usage, the Diabetes Injection Pens Market was studied across Disposable and Reusable.
  • Based on Region, the Diabetes Injection Pens Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Diabetes Injection Pens Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Diabetes Injection Pens Market, including AstraZeneca plc, Becton, Dickinson, and Company, Biocon Ltd., Eli Lilly and Company, Insulet Corporation, Jiangsu Delfu Co., Medtronic Plc, Novo Nordisk A/S, Owen Mumford Ltd, Sanofi S.A, and Ypsomed Holding AG.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Diabetes Injection Pens Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Diabetes Injection Pens Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Diabetes Injection Pens Market?
4. What is the competitive strategic window for opportunities in the Global Diabetes Injection Pens Market?
5. What are the technology trends and regulatory frameworks in the Global Diabetes Injection Pens Market?
6. What is the market share of the leading vendors in the Global Diabetes Injection Pens Market?
7. What modes and strategic moves are considered suitable for entering the Global Diabetes Injection Pens Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AstraZeneca plc
  • Biocon Ltd.
  • Eli Lilly and Company
  • Insulet Corporation
  • Jiangsu Delfu Co.
  • Medtronic Plc
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Product Outlook
3.4. Distribution Channel Outlook
3.5. Usage Outlook
3.6. Region Outlook
3.7. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of diabetic patients worldwide
5.1.1.2. Demand for intelligent insulin pen
5.1.1.3. Growth in adoption of reusable diabetes injection pen
5.1.2. Restraints
5.1.2.1. Limitation on using certain types of insulin through a pen
5.1.3. Opportunities
5.1.3.1. Easy availability and convenience through e-commerce channel
5.1.3.2. Unmet medical needs in developing nations
5.1.4. Challenges
5.1.4.1. Risk of infection due to improper use
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Diabetes Injection Pens Market, by Product
6.1. Introduction
6.2. Insulin Pens
6.3. Pen Needles

7. Diabetes Injection Pens Market, by Distribution Channel
7.1. Introduction
7.2. Diabetes Clinics
7.3. Hospital Pharmacy
7.4. Online Sales
7.5. Retail Pharmacy

8. Diabetes Injection Pens Market, by Usage
8.1. Introduction
8.2. Disposable
8.3. Reusable

9. Americas Diabetes Injection Pens Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Diabetes Injection Pens Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Thailand

11. Europe, Middle East & Africa Diabetes Injection Pens Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. AstraZeneca plc
13.2. Becton, Dickinson, and Company
13.3. Biocon Ltd.
13.4. Eli Lilly and Company
13.5. Insulet Corporation
13.6. Jiangsu Delfu Co.
13.7. Medtronic Plc
13.8. Novo Nordisk A/S
13.9. Owen Mumford Ltd
13.10. Sanofi S.A
13.11. Ypsomed Holding AG

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL DIABETES INJECTION PENS MARKET SIZE, 2020 VS 2026 (USD BILLION)
FIGURE 2. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2020 (USD BILLION)
FIGURE 3. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 (USD BILLION)
FIGURE 4. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2020 (USD BILLION)
FIGURE 5. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY REGION, 2020 (USD BILLION)
FIGURE 6. GLOBAL DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 7. GLOBAL DIABETES INJECTION PENS MARKET: MARKET DYNAMICS
FIGURE 8. GLOBAL DIABETES INJECTION PENS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 9. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
FIGURE 10. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD BILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2026
FIGURE 12. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY INSULIN PENS, 2018-2026 (USD BILLION)
FIGURE 13. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY INSULIN PENS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 14. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY PEN NEEDLES, 2018-2026 (USD BILLION)
FIGURE 15. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY PEN NEEDLES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 16. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (%)
FIGURE 17. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (USD BILLION)
FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2026
FIGURE 19. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DIABETES CLINICS, 2018-2026 (USD BILLION)
FIGURE 20. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DIABETES CLINICS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 21. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2026 (USD BILLION)
FIGURE 22. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 23. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY ONLINE SALES, 2018-2026 (USD BILLION)
FIGURE 24. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY ONLINE SALES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 25. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY RETAIL PHARMACY, 2018-2026 (USD BILLION)
FIGURE 26. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 27. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2020 VS 2026 (%)
FIGURE 28. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2020 VS 2026 (USD BILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2026
FIGURE 30. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DISPOSABLE, 2018-2026 (USD BILLION)
FIGURE 31. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DISPOSABLE, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 32. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY REUSABLE, 2018-2026 (USD BILLION)
FIGURE 33. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY REUSABLE, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 34. AMERICAS DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 35. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 36. BRAZIL DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 37. CANADA DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 38. MEXICO DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 39. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 40. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 41. AUSTRALIA DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 42. CHINA DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 43. INDIA DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 44. INDONESIA DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 45. JAPAN DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 46. MALAYSIA DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 47. PHILIPPINES DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 48. SINGAPORE DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 49. SOUTH KOREA DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 50. THAILAND DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 51. EUROPE, MIDDLE EAST & AFRICA DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 52. FRANCE DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 53. GERMANY DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 54. ITALY DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 55. NETHERLANDS DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 56. QATAR DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 57. RUSSIA DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 58. SAUDI ARABIA DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 59. SOUTH AFRICA DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 60. SPAIN DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 61. UNITED ARAB EMIRATES DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 62. UNITED KINGDOM DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 63. GLOBAL DIABETES INJECTION PENS MARKET: FPNV POSITIONING MATRIX
FIGURE 64. GLOBAL DIABETES INJECTION PENS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 65. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL DIABETES INJECTION PENS MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL DIABETES INJECTION PENS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 4. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2026 (USD BILLION)
TABLE 5. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY INSULIN PENS, BY REGION, 2018-2026 (USD BILLION)
TABLE 6. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY PEN NEEDLES, BY REGION, 2018-2026 (USD BILLION)
TABLE 7. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD BILLION)
TABLE 8. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DIABETES CLINICS, BY REGION, 2018-2026 (USD BILLION)
TABLE 9. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2026 (USD BILLION)
TABLE 10. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2026 (USD BILLION)
TABLE 11. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2026 (USD BILLION)
TABLE 12. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2026 (USD BILLION)
TABLE 13. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2026 (USD BILLION)
TABLE 14. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY REUSABLE, BY REGION, 2018-2026 (USD BILLION)
TABLE 15. AMERICAS DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 16. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 17. BRAZIL DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 18. CANADA DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 19. MEXICO DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 20. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 21. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 22. AUSTRALIA DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 23. CHINA DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 24. INDIA DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 25. INDONESIA DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 26. JAPAN DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 27. MALAYSIA DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 28. PHILIPPINES DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 29. SINGAPORE DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 30. SOUTH KOREA DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 31. THAILAND DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 32. EUROPE, MIDDLE EAST & AFRICA DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 33. FRANCE DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 34. GERMANY DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 35. ITALY DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 36. NETHERLANDS DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 37. QATAR DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 38. RUSSIA DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 39. SAUDI ARABIA DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 40. SOUTH AFRICA DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 41. SPAIN DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 42. UNITED ARAB EMIRATES DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 43. UNITED KINGDOM DIABETES INJECTION PENS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 44. GLOBAL DIABETES INJECTION PENS MARKET: SCORES
TABLE 45. GLOBAL DIABETES INJECTION PENS MARKET: BUSINESS STRATEGY
TABLE 46. GLOBAL DIABETES INJECTION PENS MARKET: PRODUCT SATISFACTION
TABLE 47. GLOBAL DIABETES INJECTION PENS MARKET: RANKING
TABLE 48. GLOBAL DIABETES INJECTION PENS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 49. GLOBAL DIABETES INJECTION PENS MARKET: MERGER & ACQUISITION
TABLE 50. GLOBAL DIABETES INJECTION PENS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 51. GLOBAL DIABETES INJECTION PENS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 52. GLOBAL DIABETES INJECTION PENS MARKET: INVESTMENT & FUNDING
TABLE 53. GLOBAL DIABETES INJECTION PENS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 54. GLOBAL DIABETES INJECTION PENS MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • AstraZeneca plc
  • Becton, Dickinson, and Company
  • Biocon Ltd.
  • Eli Lilly and Company
  • Insulet Corporation
  • Jiangsu Delfu Co.
  • Medtronic Plc
  • Novo Nordisk A/S
  • Owen Mumford Ltd
  • Sanofi S.A
  • Ypsomed Holding AG
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll